We use cookies for a better user experience. Read our Privacy Policy

I Agree

Drug Discovery Outsourcing Market

Drug Discovery Outsourcing Market (Service Type: Biological Services, Chemical Services, Lead Identification & Screening, Lead Optimization, and Others; Drug Type: Small Molecules and Large Molecules; Therapeutic Area: Respiratory System, Anti-infective, Oncology, Cardiovascular, Gastrointestinal, Central Nervous System, and Immunomodulation, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Increasing Competition and Lack of Adequate Resources in Pharmaceutical Sector to Augment Market Growth

Over the past decade, due to increasing competition, players involved in the biotech and pharmaceutical sector are primarily focusing on research and development activities to gain a competitive edge. In addition, economic environment, along with fast-paced developments on the technological front have accelerated internal as well as external innovations in the pharmaceutical space due to which, drug discovery outsourcing has gained considerable traction. External innovations largely occur in various forms at various places, including research laboratories, university labs, contract research organizations, and venture capital-based startups.

Over the past couple of decades, various challenges within the pharmaceutical sector have been well documented and point toward few key areas. The development of new drugs continues to head toward steep costs, the market competition from generics continues to grow, investors expect higher returns, and rising consumer complaints regarding high costs of drugs have led to the growth of the drug discovery outsourcing. This trend is likely to continue during the forecast period. Pharmaceutical companies are increasingly focusing on improving the efficacy of drug development and discovery.

Major developments that are likely to gain considerable traction over the next few years across the drug discovery outsourcing market include a decline in time utilized for drug development, improving the conversion rate of hits to leads, and expanding the number of high-quality compounds. At the back of these factors and evolving economic landscape, the global drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030.

To know the scope of our report Get a Sample on Drug Discovery Outsourcing Market 

Cost Benefits Associated with Drug Discovery Outsourcing to Increase Adoption

Biotech and pharmaceutical companies have consistently expressed high levels of interest in drug discovery outsourcing due to immense cost saving and various other benefits over in-house manufacturing. As per current trends, the number of small and medium-sized businesses operating in the drug discovery outsourcing market is expected to remain higher than that of larger entities due to the low number of stakeholders and fewer organizational barriers in decision-making. In addition, apart from minimizing organizational complications, small and medium-sized companies are increasingly relying on drug discovery outsourcing for product manufacturing and development due to various factors, including insufficient production ability and lack of technical expertise. These factors, along with mushrooming costs of research and development activities continue to accelerate the overall growth of the global drug discovery outsourcing market.

Challenges in Modern-day Pharmaceutical Sector and Technological Advancements Redefine Drug Development

The modern-day pharmaceutical is marred with several challenges in the drug development phase and requires considerable changes. Due to mounting challenges in drug development, drug development as well as drug discovery activities are increasingly being outsourced. Pricing pressure remains the major factor that is likely to trigger the tectonic shift in drug discovery outsourcing during the forecast period. High profit margins of pharmaceutical companies have attracted the attention of healthcare providers to add pressure pertaining to costs and reimbursement. In addition, as a result, as profit margins continue to decline several companies are evaluating the possibility of outsourcing drug discovery to third party organizations that have been equipped with required resources.

Get a glimpse of the in-depth analysis through our Report Brochure

Technological advancements have played a key role in accelerating innovations in the past decade and the trend is likely to continue in the upcoming decade. Due to fast-paced development in technology, competition in the drug discovery and drug development sectors has increased at a rapid pace. Due to the cutthroat competition, several companies in the drug discovery outsourcing market are increasingly joining hands with third-party companies to develop various cost-effective drugs.

Outsourcing of COVID-19 Drugs on Rise amid Pandemic

The ongoing COVID-19 pandemic is expected to have a low impact on the overall prospects of the global drug discovery outsourcing market. In addition, the outsourcing of drugs and medications required to manage COVID-19 infections is expected to witness considerable growth during the COVID-19 pandemic. Pharmaceutical companies are likely to turn toward domestic players for drug discovery outsourcing rather than businesses based in other regional markets. Logistical challenges, along with trade restrictions could possibly pose a barrier in the supply chain.

In addition, as the number of COVID-19 patients continues to swell around the world, pharmaceutical companies are increasingly relying on drug discovery outsourcing to fulfill the soaring demand. Several companies are expected to invest resources in research and development activities that focus on the discovery of a vaccine for the COVID-19 coronavirus. The ongoing investments in research coupled with high demand for medication to treat COVID-19 patients is expected to play a key role in boosting the growth of the drug discovery outsourcing market during the COVID-19 pandemic.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global drug discovery outsourcing market is expected to grow at an impressive CAGR of 10% during the forecast period. The market growth can be attributed to increase in research and development costs, rise in competition in the pharmaceutical sector, consumer demand for low-cost and efficient medication, and advancements in technology. Small to medium-sized pharmaceutical companies are increasingly turning to drug discovery outsourcing due to lack of adequate production capabilities & resources and lack of expertise. Although several larger companies are also expected to follow a similar path, organizational complications and discrepancies among shareholders could possibly slow down the process.

Drug Discovery Outsourcing Market: Overview

  • The global drug discovery outsourcing market was valued at ~US$ 4.5 Bn in 2019. It is projected to expand at a high CAGR from 2020 to 2030. Drug discovery contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical and biotechnology companies for drug discovery.
  • Rise in demand for drug discovery outsourcing can be attributed to the increase in focus of pharmaceutical companies on research and development and rise in focus on the development of novel drugs to meet the unmet clinical needs in various therapeutic areas including cancer, neurological disorders, and chronic diseases.

Drug Discovery Outsourcing Market: Segmentation

  • The global drug discovery outsourcing market has been segmented based on service type, drug type, therapeutic area, and region
  • In terms of service type, the global drug discovery outsourcing market has been categorized into biological services, chemical services, lead identification & screening, lead optimization, and others. The chemical services segment dominated the global drug discovery outsourcing market, in terms of value, in 2019. However, the biological services segment is likely to expand at a high CAGR during the forecast period.
  • Based on drug type, the global drug discovery outsourcing market has been classified into small molecules and large molecules. The small molecules segment dominated the drug discovery outsourcing market in 2019 and is likely to remain dominant in the forecast period. In terms of therapeutic area, the global drug discovery outsourcing market has been divided into respiratory system, anti-infective, oncology, cardiovascular, gastrointestinal, central nervous system, immunomodulation, and others. Oncology segment dominated the global drug discovery outsourcing market in 2019.

Drug Discovery Outsourcing Market: Regional Segmentation

  • In terms of region, the global drug discovery outsourcing market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global drug discovery outsourcing market in 2019, and the trend is expected to continue during the forecast period. Expansion of the drug discovery outsourcing market in the region can be attributed to an increase in focus on discovering medicines for the treatment of rise in pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. Additionally, an increase in investments in research & development (R&D) by large pharmaceutical and biotechnology companies and their focus on streamlining internal costs leading to the drug discovery outsourcing process fuels the market.
  • The drug discovery outsourcing market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. Expansion of the drug discovery outsourcing market in the region can be attributed to an increase in focus of pharmaceutical companies on the region as a favorable site for drug discovery outsourcing processes.

Drug Discovery Outsourcing Market: Major Players

  • Key players operating in the global drug discovery outsourcing market include 
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • WuXi AppTec Co., Ltd.
    • Albany Molecular Research Inc. (AMRI)
    • GVK Biosciences Private Limited
    • Sygnature Discovery
    • Pharmaron Beijing Co., Ltd
    • WuXi Biologics (Cayman), Inc.
    • Domainex Ltd.
    • Thermo Fisher Scientific, Inc.
    • Jubilant Biosys Ltd.
    • Evotec SE
    • Eurofins Discovery, 
    • GenScript Biotech Corporation
  • The market players in the drug discovery outsourcing market have been adopting inorganic growth strategies to consolidate their position in the global drug discovery outsourcing market. For instance, in February 2020, Charles River acquired Citoxlab for US$ 510 Mn. Citoxlab is a non-clinical CRO company that specializes in regulated safety assessment services, nonregulated discovery services, and medical device testing. In January 2018, Spectris acquired Concept Life Sciences from Equistone Partners Europe. Concept Life Sciences is the U.K.-based provider of drug discovery, development, analytical testing, and environmental consultancy services drug discovery and development services.

Drug Discovery Outsourcing Market – Segmentation

Service Type

Biological Services

Chemical Services

Lead Identification & Screening

Lead Optimization

Others

Drug Type

Small Molecules

Large Molecules

Therapeutic Area

Respiratory System

Anti-infective

Oncology

Cardiovascular

Gastrointestinal

Central Nervous System

Immunomodulation

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Drug Discovery Outsourcing Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of Drug Discovery Outsourcing Market?

Drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030

Which region is expected to project the highest market share in the global Drug Discovery Outsourcing Market?

North America dominated the global drug discovery outsourcing market in 2019, and the trend is expected to continue during the forecast period

What are the key driving factors for the growth of the Drug Discovery Outsourcing Market?

Drug Discovery Outsourcing Market is driven by rise in penetration of contract research organizations for pre-clinical research, increase in investments in research and development (R&D) and a surge in the demand for personalized medicines

Which is the rising prominent segment in the Drug Discovery Outsourcing Market?

The small molecules segment is anticipated to account for a major share of the global drug discovery outsourcing market during the forecast period

Who are the key players in the global Drug Discovery Outsourcing Market?

Key players operating in the global drug discovery outsourcing market are CHARLES RIVER LABORATORIES INTERNATIONAL, INC., WuXi AppTec Co., Ltd., Albany Molecular Research Inc. (AMRI), GVK Biosciences Private Limited, Sygnature Discovery

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Discovery Outsourcing Market

4. Market Overview

    4.1. Definition

    4.2. Market Indicators

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    4.5. Global Drug Discovery Outsourcing Market Outlook

5. Key Insights

    5.1. Key Mergers & Acquisition

    5.2. Technological Advancements in Drug Discovery

    5.3. Drug Discovery Process – an Overview

    5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry

    5.5. Overview of Companies outsourcing to CROs

    5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced

6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type 

    6.1. Introduction 

    6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type

    6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        6.3.1. Biological Services

        6.3.2. Chemical Services

        6.3.3. Lead Identification & Screening

        6.3.4. Lead Optimization

        6.3.5. Others

    6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type 

7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type

    7.1. Introduction 

    7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type

    7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        7.3.1. Small Molecules

        7.3.2. Large Molecules

    7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type

8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area

    8.1. Introduction 

    8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area

    8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        8.3.1. Respiratory System

        8.3.2. Anti-infective

        8.3.3. Oncology

        8.3.4. Cardiovascular

        8.3.5. Gastrointestinal

        8.3.6. Central Nervous System

        8.3.7. Immunomodulation

        8.3.8. Others

    8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area

9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region 

    9.1. Regional Outlook

    9.2. Introduction

    9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region

        9.3.1. North America

        9.3.2. Europe 

        9.3.3. Asia Pacific

        9.3.4. Latin America 

        9.3.5. Middle East & Africa

    9.4.  Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region

10. North America Drug Discovery Outsourcing Market Analysis and Forecast

    10.1.  Key Findings

    10.2.  North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        10.2.1. Biological Services

        10.2.2. Chemical Services

        10.2.3. Lead Identification & Screening

        10.2.4. Lead Optimization

        10.2.5. Others 

    10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        10.3.1. Small Molecules 

        10.3.2. Large Molecules

    10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        10.4.1. Respiratory System

        10.4.2. Anti-infective

        10.4.3. Oncology

        10.4.4. Cardiovascular

        10.4.5. Gastrointestinal

        10.4.6. Central Nervous System

        10.4.7. Immunomodulation

        10.4.8. Others

    10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis

        10.6.1. By Service Type

        10.6.2. By Drug Type

        10.6.3. By Therapeutic Area

        10.6.4. By Country

11. Europe Drug Discovery Outsourcing Market Analysis and Forecast

    11.1.  Key Findings

    11.2.  Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        11.2.1. Biological Services

        11.2.2. Chemical Services

        11.2.3. Lead Identification & Screening

        11.2.4. Lead Optimization

        11.2.5. Others 

    11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        11.3.1. Small Molecules 

        11.3.2. Large Molecules

    11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        11.4.1. Respiratory System

        11.4.2. Anti-infective

        11.4.3. Oncology

        11.4.4. Cardiovascular

        11.4.5. Gastrointestinal

        11.4.6. Central Nervous System

        11.4.7. Immunomodulation

        11.4.8. Others

    11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. U.K.

        11.5.2. Germany

        11.5.3. France

        11.5.4. Italy 

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis

        11.6.1. By Service Type

        11.6.2. By Drug Type

        11.6.3. By Therapeutic Area

        11.6.4. By Country/Sub-region

12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast

    12.1.  Key Findings

    1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        12.1.1. Biological Services

        12.1.2. Chemical Services

        12.1.3. Lead Identification & Screening

        12.1.4. Lead Optimization

        12.1.5. Others 

    12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        12.2.1. Small Molecules 

        12.2.2. Large Molecules

    12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        12.3.1. Respiratory System

        12.3.2. Anti-infective

        12.3.3. Oncology

        12.3.4. Cardiovascular

        12.3.5. Gastrointestinal

        12.3.6. Central Nervous System

        12.3.7. Immunomodulation

        12.3.8. Others

    12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

        12.4.1. China

        12.4.2. India

        12.4.3. Japan

        12.4.4. Australia & New Zealand 

        12.4.5. Rest of Asia Pacific 

    12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis

        12.5.1. By Service Type

        12.5.2. By Drug Type

        12.5.3. By Therapeutic Area 

        12.5.4. By Country/Sub-region

13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast

    13.1.  Key Findings

    13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        13.2.1. Biological Services

        13.2.2. Chemical Services

        13.2.3. Lead Identification & Screening

        13.2.4. Lead Optimization

        13.2.5. Others 

    13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        13.3.1. Small Molecules 

        13.3.2. Large Molecules

    13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        13.4.1. Respiratory System

        13.4.2. Anti-infective

        13.4.3. Oncology

        13.4.4. Cardiovascular

        13.4.5. Gastrointestinal

        13.4.6. Central Nervous System

        13.4.7. Immunomodulation

        13.4.8. Others

    13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil 

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis

        13.6.1. By Service Type

        13.6.2. By Drug Type

        13.6.3. By Therapeutic Area

        13.6.4. By Country/Sub-region

14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast

    14.1.  Key Findings

    14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

        14.2.1. Biological Services

        14.2.2. Chemical Services

        14.2.3. Lead Identification & Screening

        14.2.4. Lead Optimization

        14.2.5. Others 

    14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

        14.3.1. Small Molecules 

        14.3.2. Large Molecules

    14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

        14.4.1. Respiratory System

        14.4.2. Anti-infective

        14.4.3. Oncology

        14.4.4. Cardiovascular

        14.4.5. Gastrointestinal

        14.4.6. Central Nervous System

        14.4.7. Immunomodulation

        14.4.8. Others

    14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries 

        14.5.2. South Africa 

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis

        14.6.1. By Service Type

        14.6.2. By Drug Type

        14.6.3. By Therapeutic Area

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1.  Market Player - Competition Matrix (by tier and size of companies)

    15.2.  Market Share Analysis, by Company, 2019

    15.3. Company Profiles

        15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.  

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. WuXi AppTec Co., Ltd.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3. Albany Molecular Research Inc. (AMRI)

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4. GVK Biosciences Private Limited

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. Sygnature Discovery

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. Pharmaron Beijing Co., Ltd.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. WuXi Biologics (Cayman), Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8. Domainex Ltd.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. Thermo Fisher Scientific, Inc.

            15.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Overview

            15.3.9.3. Product Portfolio

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis

        15.3.10.  Jubilant Biosys Ltd.

            15.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Financial Overview

            15.3.10.3. Product Portfolio

            15.3.10.4. Strategic Overview

            15.3.10.5. SWOT Analysis

        15.3.11.  Evotec SE

            15.3.11.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Financial Overview

            15.3.11.3. Product Portfolio

            15.3.11.4. Strategic Overview

            15.3.11.5. SWOT Analysis

        15.3.12.  Eurofins Discovery

            15.3.12.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.12.2. Financial Overview

            15.3.12.3. Product Portfolio

            15.3.12.4. Strategic Overview

            15.3.12.5. SWOT Analysis

        15.3.13.  GenScript Biotech Corporation

            15.3.13.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.13.2. Financial Overview

            15.3.13.3. Product Portfolio

            15.3.13.4. Strategic Overview

            15.3.13.5. SWOT Analysis

List of Tables

Table 01: Companies entering into partnerships with CROs for drug discovery

Table 02: Integrated Drug Discovery – Key Players

Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

List of Figures

Figure 01: Global Drug Discovery Outsourcing Market

Figure 02: Global Drug Discovery Outsourcing Market Size (US$ Mn) Forecast, 2018–2030

Figure 03: Global Drug Discovery Outsourcing market Value Share, by Service Type, 2020

Figure 04: Global Drug Discovery Outsourcing Market Value Share, by Drug Type, 2020

Figure 05: Global Drug Discovery Outsourcing Market Value Share, by Therapeutic Area, 2020

Figure 06: Global Drug Discovery Outsourcing Market Value Share, by Region, 2020

Figure 07: CRO Services Market – Key Mergers and Acquisitions

Figure 08: Technological Advancements in Drug Discovery

Figure 09: Drug Discovery & Development Process – an Overview 

Figure 10: Drug Discovery Process – an Overview 

Figure 11: IDD Trends

Figure 12: IDD Business Models

Figure 13: IDD- Types of Projects

Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 15: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 16: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biological Services, 2018–2030

Figure 17: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chemical Services, 2018–2030

Figure 18: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Identification & Screening, 2018–2030

Figure 19: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Optimization, 2018–2030

Figure 20: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 21: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 22: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

Figure 23: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Small Molecules, 2018–2030

Figure 24: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Large Molecules, 2018–2030

Figure 25: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 26: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

Figure 27: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory System, 2018–2030

Figure 28: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-infective, 2018–2030

Figure 29: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2018–2030

Figure 30: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular, 2018–2030

Figure 31: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal, 2018–2030

Figure 32: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Central Nervous System, 2018–2030

Figure 33: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunomodulation, 2018–2030

Figure 34: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 35: Global Drug Discovery Outsourcing Market: Regional Outlook

Figure 36: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 37: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2019 and 2030

Figure 38: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2020–2030

Figure 39: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 40: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2019 and 2030

Figure 41: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2020–2030

Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 45: North America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 47: North America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 48: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 49: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 51: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 52: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 53: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 54: Europe Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 55: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 56: Europe Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 57: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 58: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 59: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 61: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 62: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 63: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

Figure 64: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 65: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

Figure 66: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 67: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 68: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 69: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 70: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 71: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 72: Latin America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 73: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 74: Latin America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 75: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 76: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 77: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 78: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 79: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 80: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 81: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 82: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 83: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 84: Global Drug Discovery Outsourcing Market Analysis, by Top Company Ranking, 2019

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

845

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved